To what extent can our intestinal microbiota predict the risk of developing diseases? In the case of multifactorial diseases, bacterial taxa alone do not provide much information, according to a study ...
Genome-wide association studies (GWAS) are effective in detecting common alleles that contribute to the inherited component of common multifactorial diseases. Typically, the alleles identified by this ...
A research team provides an overview of how engineered probiotics—genetically modified beneficial microbes—are being transformed into living medicines capable of sensing disease, delivering therapies, ...
A combination of silybin and carvedilol for treating liver fibrosis is more effective than either drug alone. | Drug ...
TechBio company MultiOmic Health (MOH) initially set out to build an artificial intelligence (AI)-enabled platform to research metabolic dysfunction-associated conditions. In just three years, not ...
PALO ALTO, Calif., May 1, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to ...
Real-world adverse events are rarely monocausal. They emerge from the interaction of drug exposure, comorbid conditions, physiological states, concomitant medications, and patient-specific ...
An additional 42 genes connected to the development of Alzheimer’s disease have been uncovered in the largest study of genetic risk for Alzheimer’s to date. “This is a landmark study in the field of ...
"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback